• Western blot analysis of lysates from HpeG2 cells, primary antibody was diluted at 1:1000, 4°C over night

Anti-OSGIN1 antibody (276-326 aa) (STJ193537)

SKU:
STJ193537

Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Rat/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Oxidative stress-induced growth inhibitor 1 (276-326 aa) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: OSGIN1
Gene ID: 29948
Uniprot ID: OSGI1_HUMAN
Immunogen Region: 276-326 aa
Specificity: This antibody detects endogenous levels of OSGI1 at Human
Immunogen: Synthesized peptide derived from the human OSGI1 at the amino acid range 276-326
Function Regulates the differentiation and proliferation through the regulation of cell death.
Protein Name Oxidative Stress-Induced Growth Inhibitor 1
Bone Marrow Stromal Cell-Derived Growth Inhibitor
Bmsc-Derived Growth Inhibitor
Ovary - Kidney And Liver Protein 38
Huokl38
Pregnancy-Induced Growth Inhibitor Okl38
Alternative Antibody Names Anti-Oxidative Stress-Induced Growth Inhibitor 1 antibody
Anti-Bone Marrow Stromal Cell-Derived Growth Inhibitor antibody
Anti-Bmsc-Derived Growth Inhibitor antibody
Anti-Ovary - Kidney And Liver Protein 38 antibody
Anti-Huokl38 antibody
Anti-Pregnancy-Induced Growth Inhibitor Okl38 antibody
Anti-OSGIN1 antibody
Anti-BDGI antibody
Anti-OKL38 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance